Taken together, nuclear DNAJB6 plays a critical role in the development and lymph node metastasis of ESCC, reducing AKT signaling and suggesting its potential for development as a prognostic and therapeutic biomarker for ESCC [88]. This evidence concerns the gene DNAJB6 and esophageal squamous cell carcinoma.